Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dispenzieri

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Bone Marrow Transplantation|September 6, 2001
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantationW J Hogan, M Q Lacy, G A Wiseman, et al.
Clinical Genetics|September 12, 2014
Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosisD B Zhen, P L Swiecicki, S R Zeldenrust, et al.
Leukemia|September 6, 2013
Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaA J Greenberg, S V Rajkumar, T M Therneau, et al.
AJNR. American Journal of Neuroradiology|January 19, 2008
Vertebroplasty in multiple myeloma: outcomes in a large patient seriesR J McDonald, A T Trout, L A Gray, et al.
Leukemia|November 28, 2012
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaJ T Larsen, S K Kumar, A Dispenzieri, et al.
Bone Marrow Transplantation|March 21, 2007
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myelomaM A Gertz, M Q Lacy, A Dispenzieri, et al.
Bone Marrow Transplantation|June 19, 2008
Impact of additional cytoreduction following autologous SCT in multiple myelomaSk Kumar, D Dingli, A Dispenzieri, et al.
Gene Therapy|April 6, 2012
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic virusesK-W Peng, R Myers, A Greenslade, et al.
Bone Marrow Transplantation|September 12, 2007
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL)M A Gertz, M Q Lacy, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Bone Marrow Transplantation|September 6, 2001
Successful treatment of POEMS syndrome with autologous hematopoietic progenitor cell transplantationW J Hogan, M Q Lacy, G A Wiseman, et al.
Clinical Genetics|September 12, 2014
Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosisD B Zhen, P L Swiecicki, S R Zeldenrust, et al.
Leukemia|September 6, 2013
Relationship between initial clinical presentation and the molecular cytogenetic classification of myelomaA J Greenberg, S V Rajkumar, T M Therneau, et al.
AJNR. American Journal of Neuroradiology|January 19, 2008
Vertebroplasty in multiple myeloma: outcomes in a large patient seriesR J McDonald, A T Trout, L A Gray, et al.
Leukemia|November 28, 2012
Serum free light chain ratio as a biomarker for high-risk smoldering multiple myelomaJ T Larsen, S K Kumar, A Dispenzieri, et al.
Bone Marrow Transplantation|March 21, 2007
Impact of age and serum creatinine value on outcome after autologous blood stem cell transplantation for patients with multiple myelomaM A Gertz, M Q Lacy, A Dispenzieri, et al.
Bone Marrow Transplantation|June 19, 2008
Impact of additional cytoreduction following autologous SCT in multiple myelomaSk Kumar, D Dingli, A Dispenzieri, et al.
Gene Therapy|April 6, 2012
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic virusesK-W Peng, R Myers, A Greenslade, et al.
Bone Marrow Transplantation|September 12, 2007
Transplantation without growth factor: engraftment kinetics after stem cell transplantation for primary systemic amyloidosis (AL)M A Gertz, M Q Lacy, A Dispenzieri, et al.
Blood Cancer Journal|October 27, 2015
Characteristics of exceptional responders to lenalidomide-based therapy in multiple myelomaT Vu, W Gonsalves, S Kumar, et al.
Pageof 16